Phathom Pharmaceuticals Aktie
WKN DE: A2PT0F / ISIN: US71722W1071
06.10.2025 14:18:49
|
Phathom Pharmaceuticals Appoints Sanjeev Narula As Chief Financial And Business Officer
(RTTNews) - Phathom Pharmaceuticals, Inc. (PHAT), on Monday, announced that it has appointed Sanjeev Narula as Chief Financial and Business Officer.
Sanjeev Narula has extensive financial and operational expertise and most recently served as CFO at Intra-Cellular Therapies. Narula had previously served in senior finance roles at Pfizer.
Narula said that to drive financial performance and VOQUEZNA gaining traction and a clear path for continued growth.
In the pre-market trading, Phathom Pharmaceuticals is 1.97% higher at $12.45 on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Phathom Pharmaceuticals Inc Registered Shsmehr Nachrichten
06.08.25 |
Ausblick: Phathom Pharmaceuticals informiert über die jüngsten Quartalsergebnisse (finanzen.net) | |
30.04.25 |
Ausblick: Phathom Pharmaceuticals präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Phathom Pharmaceuticals Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Phathom Pharmaceuticals Inc Registered Shs | 11,61 | -4,91% |
|